This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Obama Health Care Plan Squeezes ETFs

The nightmare scenario for health insurers, a "Medicare for All" system like the one Representative Dennis Kucinich envisioned in his 2005 bill, could put many of these companies out of business. On the other hand, the U.S. automobile industry and other sectors consider the end of company-sponsored health care the route to international competitiveness.

Worst-Performing Healthcare & Biotechnology Funds for the Week Ending Thursday, Feb. 26
Fund (Ticker) Rating
Fund Type
1 Week Total Return
iShares Dow Jones US Healthcare Providers Index Fund (IHF) C-
ETF
-16.31%
ProShares Ultra Health Care (RXL) D+
ETF
-15.83%
Fidelity Select Medical Delivery Portfolio (FSHCX) C+
Open-End
-15.60%
ProFunds Health Care UltraSector ProFund (HCPIX) C+
Open-End
-12.20%
PowerShares Dynamic Healthcare Services Portfolio (PTJ) D-
ETF
-12.01%
PowerShares Dynamic Healthcare Sector Portfolio (PTH) C
ETF
-10.81%
John Hancock Health Sciences Fund (JHGRX) C+
Open-End
-10.53%
ProFunds Pharmaceuticals UltraSector ProFund (PHPIX) B-
Open-End
-10.32%
Hartford Global Health HLS Fund (HIAHX) U
Open-End
-9.39%
Vanguard Health Care Fund (VGHCX) A-
Open-End
-9.02%
Source: Bloomberg & TheStreet.com Ratings

The C-rated ProShares UltraShort Health Care Fund (RXD), which bets on falling stocks, advanced 17%.

Two Rydex ETFs lacked trading activity on Feb. 19, so comparable return data isn't available. But based on the funds' net asset values, the Rydex Inverse 2X S&P Select Sector Health Care ETF (RHO) gained 18%, while the bullish equivalent, Rydex 2X S&P Select Sector Health Care ETF (RHM) lost 17%. These 200% leveraged funds would have been the best- and worst-performing health-care funds last week.

Until the uncertainty surrounding the health-care system is resolved, the outlook for health and biotechnology shares and the funds that hold them remains murky.

For more information, check out an explanation of our ratings.
Kevin Baker became the senior financial analyst for TSC Ratings upon the August 2006 acquisition of Weiss Ratings by TheStreet.com, covering mutual funds. He joined the Weiss Group in 1997 as a banking and brokerage analyst. In 1999, he created the Weiss Group's first ratings to gauge the level of risk in U.S. equities. Baker received a B.S. degree in management from Rensselaer Polytechnic Institute and an M.B.A. with a finance specialization from Nova Southeastern University.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
RXL $62.25 -5.71%
IHF $128.86 -2.56%
HUM $180.45 -1.30%
UNH $113.83 -1.60%
WCG $88.31 -2.60%

Markets

Chart of I:DJI
DOW 16,176.87 +118.52 0.74%
S&P 500 1,913.85 -58.33 -2.96%
NASDAQ 4,636.1050 -140.4030 -2.94%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs